Early intervention in Bipolar disorder

American Journal of Psychiatry

Volumn 175, Issue 5, 2018, Pages 411-426

  Vieta, Eduard ^a   Salagre, Estela ^a   Grande, Iria ^a   Carvalho, André F ^a   Fernandes, Brisa S ^a   Berk, Michael ^a   Birmaher, Boris ^a   Tohen, Mauricio ^a   Suppes, Trisha ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BIOLOGICAL MARKER; FOLIC ACID; LITHIUM SALT; OMEGA 3 FATTY ACID; PLACEBO; QUETIAPINE; VALPROIC ACID;

BEHAVIOR; BIPOLAR DISORDER; BIPOLAR MANIA; CHEMOPROPHYLAXIS; DEPRESSION; DISEASE COURSE; DRUG RESPONSE; EARLY INTERVENTION; ENDOCRINE DISEASE; ENVIRONMENTAL FACTOR; HUMAN; INCIDENCE; MOOD DISORDER; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PSYCHOEDUCATION; PSYCHOSIS; PSYCHOTHERAPY; REVIEW; RISK BENEFIT ANALYSIS; RISK FACTOR; SCREENING TEST; SYMPTOM; THERAPY EFFECT; VITAMIN SUPPLEMENTATION; ADOLESCENT; ADULT; BLOOD; CHILD; EARLY DIAGNOSIS; GENETIC PREDISPOSITION; GENETICS; MASS SCREENING; PRODROMAL SYMPTOM; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; BIOMARKERS; BIPOLAR DISORDER; CHILD; EARLY DIAGNOSIS; EARLY MEDICAL INTERVENTION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MASS SCREENING; PRODROMAL SYMPTOMS; PSYCHIATRIC STATUS RATING SCALES; RISK FACTORS; YOUNG ADULT;

EID: 85042634082     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2017.17090972     Document Type: Review

References (157)

1. Mayo WJ: The aims and ideals of the American Medical Association. Proceedings and Addresses of the National Education Association 1928;66:163
2. Jacka FN, ReavleyNJ, Jorm AF, et al: Prevention of common mental disorders: what can we learn from those who have gone before and where do we go next? Aust N Z J Psychiatry 2013;47:920-929
3. Clarke EA: What is preventive medicine? Can Fam Physician 1974;20:65-68
4. Berk M, Berk L, Dodd S, et al: Stage managing bipolar disorder. Bipolar Disord 2014;16:471-477
5. Kapczinski NS, Mwangi B, Cassidy RM, et al: Neuroprogression and illness trajectories in bipolar disorder. Expert Rev Neurother 2017;17:277-285
6. Vieta E, Popovic D, Rosa AR, et al: The clinical implications of cognitive impairment and allostatic load in bipolar disorder. Eur Psychiatry 2013;28:21-29
7. Baldessarini RJ, Bolzani L, Cruz N, et al: Onset-age of bipolar disordersatsix internationalsites. J Affect Disord 2010;121:143-146
8. Chengappa KN, Kupfer DJ, Frank E, et al: Relationship of birth cohort and early age at onset of illness in a bipolar disorder case registry. Am J Psychiatry 2003;160:1636-1642
9. Perlis RH, Dennehy EB, Miklowitz DJ, et al: Retrospective age at onset of bipolar disorder and outcome during two-year follow-up: results from the STEP-BD study. Bipolar Disord 2009;11:391-400
10. Bellivier F, Golmard JL, Rietschel M, et al: Age at onset in bipolar I affective disorder: further evidence for three subgroups. Am J Psychiatry 2003;160:999-1001
11. Merikangas KR, Akiskal HS, Angst J, et al: Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry 2007;64:543-552
12. Kraepelin E: Manic-depressive insanity and paranoia. Edinburgh, Livingstone, 1921
13. Tohen M, Hennen J, Zarate CM Jr, et al: Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features. Am J Psychiatry 2000;157:220-228
14. Duffy A, Alda M, Hajek T, et al: Early stages in the development of bipolar disorder. J Affect Disord 2010;121:127-135
15. Bolman WM, Westman JC: Prevention of mental disorder: an overview of current programs. Am J Psychiatry 1967;123:1058-1068
16. Eaton WW, Badawi M, Melton B: Prodromes and precursors: epidemiologic data for primary prevention of disorders with slow onset. Am J Psychiatry 1995;152:967-972
17. Baethge C, Baldessarini RJ, Khalsa HM, et al: Substance abuse in first-episode bipolar I disorder: indications for early intervention. Am J Psychiatry 2005;162:1008-1010
18. Schooler N, Rabinowitz J, Davidson M, et al: Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial. Am J Psychiatry 2005;162:947-953
19. Goi PD, Bucker J, Vianna-Sulzbach M, et al: Pharmacological treatment and staging in bipolar disorder: evidence from clinical practice. Rev Bras Psiquiatr 2015;37:121-125
20. Tohen M, Vieta E, Gonzalez-Pinto A, et al: Baseline characteristics and outcomes in patients with first episode or multiple episodes of acute mania. J Clin Psychiatry 2010;71:255-261
21. Joyce K, Thompson A, Marwaha S: Istreatment for bipolardisorder more effective earlier in illness course? A comprehensive literature review. Int J Bipolar Disord 2016;4:19
22. McGuffin P, Rijsdijk F, Andrew M, et al: The heritability of bipolar affective disorder and the genetic relationship to unipolar depression. Arch Gen Psychiatry 2003;60:497-502
23. Bortolato B, Köhler CA, Evangelou E, et al: Systematic assessment of environmental risk factors for bipolar disorder: an umbrella review of systematic reviews and meta-analyses. Bipolar Disord 2017;19:84-96
24. Post RM, Altshuler L, Leverich G, et al: More stressors prior to and during the course of bipolar illness in patients from the United States compared with the Netherlands and Germany. Psychiatry Res 2013;210:880-886
25. Post RM, Altshuler LL, Kupka R, et al: Age of onset of bipolar disorder: Combined effect of childhood adversity and familial loading of psychiatric disorders. J Psychiatr Res 2016;81:63-70
26. Doucette S, Levy A, Flowerdew G, et al: Early parent-child relationships and risk of mood disorder in a Canadian sample of offspring of a parent with bipolar disorder: findings from a 16-year prospective cohort study. Early Interv Psychiatry 2016;10:381-389
27. Kemner SM, Mesman E, Nolen WA, et al: The role of life events and psychological factors in the onset of first and recurrent mood episodesinbipolar offspring: results from the Dutch Bipolar Offspring Study. Psychol Med 2015;45:2571-2581
28. Wals M, Hillegers MH, Reichart CG, et al: Stressful life events and onset of mood disorders in children of bipolar parents during 14-month follow-up. J Affect Disord 2005;87:253-263
29. Birmaher B, Gill MK, Axelson DA, et al: Longitudinal trajectories and associated baseline predictors in youths with bipolar spectrum disorders. Am J Psychiatry 2014;171:990-999
30. Jiménez E, Solé B, Arias B, et al: Impact of childhood trauma on cognitive profile in bipolar disorder. Bipolar Disord 2017;19:363-374
31. Greenfield SF, Strakowski SM, Tohen M, et al: Childhood abuse in first-episode psychosis. Br J Psychiatry 1994;164:831-834
32. Leverich GS, McElroy SL, Suppes T, et al: Early physical and sexual abuse associated with an adverse course of bipolar illness. Biol Psychiatry 2002;51:288-297
33. Berk M, Moylan S, Jacka FN: A royal gift to prevention efforts. Aust N Z J Psychiatry 2014;48:110-111
34. Martin A, Young C, Leckman JF, et al: Age effects on antidepressantinduced manic conversion. Arch Pediatr Adolesc Med 2004;158:773-780
35. Barbuti M, Pacchiarotti I, Vieta E, et al: Antidepressant-induced hypomania/maniainpatientswithmajor depression: evidence from the BRIDGE-II-MIX study. J Affect Disord 2017;219:187-192
36. Tohen M, Greenfield SF, Weiss RD, et al: The effect of comorbid substance use disorders on the course of bipolar disorder: a review. Harv Rev Psychiatry 1998;6:133-141
37. Ratheesh A, Cotton SM, Betts JK, et al: Prospective progression from high-prevalence disorders to bipolar disorder: Exploring characteristics of pre-illness stages. J Affect Disord 2015;183:45-48
38. Duffy A, Horrocks J, Doucette S, et al: The developmental trajectory of bipolar disorder. Br J Psychiatry 2014;204:122-128
39. Goldstein BI, Strober M, Axelson D, et al: Predictors of first-onset substance use disorders during the prospective course of bipolar spectrum disorders in adolescents. J Am Acad Child Adolesc Psychiatry 2013;52:1026-1037
40. Tohen M, Zarate CA Jr, Hennen J, et al: The McLean-Harvard First-Episode Mania Study: prediction of recovery and first recurrence. Am J Psychiatry 2003;160:2099-2107
41. Pasco JA, Williams LJ, Jacka FN, et al: Tobacco smoking as a risk factor for major depressive disorder: population-based study. Br J Psychiatry 2008;193:322-326
42. Quinn PD, Rickert ME, Weibull CE, et al: Association between maternal smoking during pregnancy and severe mental illness in offspring. JAMA Psychiatry 2017;74:589-596
43. Moylan S, Gustavson K, Øverland S, et al: The impact of maternal smoking during pregnancy on depressive and anxiety behaviors in children: the Norwegian Mother and Child Cohort Study. BMC Med 2015;13:24
44. Salvatore P, Baldessarini RJ, Khalsa HM, et al: Antecedents of manic versus other first psychotic episodes in 263 bipolar I disorder patients. Acta Psychiatr Scand 2014;129:275-285
45. Hafeman DM, Merranko J, Axelson D, et al: Toward the definition of a bipolar prodrome: dimensional predictors of bipolar spectrum disorders in at-risk youths. Am J Psychiatry 2016;173:695-704
46. Preisig M, Strippoli MF, Castelao E, et al: The specificity of the familial aggregation of early-onset bipolar disorder: A controlled 10-year follow-up study of offspring of parents with mood disorders. J Affect Disord 2016;190:26-33
47. Betts KS, Williams GM, Najman JM, et al: Predicting spectrums of adult mania, psychosis and depressionby prospectively ascertained childhood neurodevelopment. J Psychiatr Res 2016;72:22-29
48. MacCabe JH, Lambe MP, Cnattingius S, et al: Excellent school performance at age 16 and risk of adult bipolar disorder: national cohort study. Br J Psychiatry 2010;196:109-115
49. Axelson D, Goldstein B, Goldstein T, et al: Diagnostic precursors to bipolar disorder in offspring of parents with bipolar disorder: a longitudinal study. Am J Psychiatry 2015;172:638-646
50. Egeland JA, Endicott J, Hostetter AM, et al: A 16-year prospective study of prodromal features prior to BPI onset in well Amish children. J Affect Disord 2012;142:186-192
51. Carlson GA, Weintraub S: Childhood behavior problems and bipolar disorder: relationship or coincidence? J Affect Disord 1993;28:143-153
52. Mesman E, Nolen WA, Reichart CG, et al: The Dutch bipolar offspring study: 12-year follow-up. Am J Psychiatry 2013;170:542-549
53. Akiskal HS, Downs J, Jordan P, et al: Affective disorders in referred children and younger siblings of manic-depressives: mode of onset and prospective course. Arch Gen Psychiatry 1985;42:996-1003
54. Duffy A, Horrocks J, Doucette S, et al: Childhood anxiety: an early predictorof mood disorders inoffspringof bipolar parents. J Affect Disord 2013;150:363-369
55. Lewinsohn PM, Klein DN, Seeley JR: Bipolar disorders in a community sample of older adolescents: prevalence, phenomenology, comorbidity, and course. J Am Acad Child Adolesc Psychiatry 1995;34:454-463
56. Levenson JC, Axelson DA, Merranko J, et al: Differences in sleep disturbances among offspring of parents with and without bipolar disorder: association with conversion to bipolar disorder. Bipolar Disord 2015;17:836-848
57. Boschloo L, Spijker AT, Hoencamp E, et al: Predictors of the onset of manic symptoms and a (hypo) manic episode in patients with major depressive disorder. PLoS One 2014;9:e106871
58. Papachristou E, Oldehinkel AJ, Ormel J, et al: The predictive value of childhood subthreshold manic symptoms for adolescent and adult psychiatric outcomes. J Affect Disord 2017;212:86-92
59. Ratheesh A, Cotton SM, Davey CG, et al: Pre-onset risk characteristics for mania among young people at clinical high risk for psychosis. Schizophr Res (Epub ahead of print, July 30, 2017)
60. Haenisch F, Cooper JD, Reif A, et al: Towards a blood-based diagnostic panel for bipolar disorder. Brain Behav Immun 2016;52:49-57
61. Mesman E, Nolen WA, Keijsers L, et al: Baseline dimensional psychopathology and future mood disorder onset: findings from the Dutch Bipolar Offspring Study. Acta Psychiatr Scand 2017;136:201-209
62. Axelson DA, Birmaher B, Strober MA, et al: Course of subthreshold bipolar disorder in youth: diagnostic progression from bipolar disorder not otherwise specified. J Am Acad Child Adolesc Psychiatry 2011;50:1001-1016.e3
63. Alloy LB, Urosevic S, Abramson LY, et al: Progression along the bipolar spectrum: a longitudinal study of predictors of conversion from bipolar spectrum conditions to bipolar I and II disorders. J Abnorm Psychol 2012;121:16-27
64. Van Meter AR, Burke C, Youngstrom EA, et al: The bipolar prodrome: meta-analysis of symptom prevalence prior to initial or recurrent mood episodes. J Am Acad Child Adolesc Psychiatry 2016;55:543-555
65. Grande I, Berk M, Birmaher B, et al: Bipolar disorder. Lancet 2016;387:1561-1572
66. Goldberg JF, Harrow M, Whiteside JE: Risk for bipolar illness in patients initially hospitalized for unipolar depression. Am J Psychiatry 2001;158:1265-1270
67. Østergaard SD, Straszek S, Petrides G, et al: Risk factors for conversion from unipolar psychotic depression to bipolar disorder. Bipolar Disord 2014;16:180-189
68. Strober M, Carlson G: Bipolar illness in adolescents with major depression: clinical, genetic, and psychopharmacologic predictors in a three- to four-year prospective follow-up investigation. Arch Gen Psychiatry 1982;39:549-555
69. Tohen M, Khalsa HK, Salvatore P, et al: Two-year outcomes in firstepisode psychotic depression the McLean-Harvard First-Episode Project. J Affect Disord 2012;136:1-8
70. Ratheesh A, Davey C, Hetrick S, et al: A systematic review and metaanalysis of prospective transition from major depression to bipolar disorder. Acta Psychiatr Scand 2017;135:273-284
71. Verdolini N, Perugi G, Samalin L, et al: Aggressiveness in depression: a neglected symptom possibly associated with bipolarity and mixed features. Acta Psychiatr Scand 2017;136:362-372
72. Salvatore P, BaldessariniRJ, KhalsaHM, etal: Predicting diagnostic change among patients diagnosed with first-episode DSM-IV-TR major depressive disorder with psychotic features. J Clin Psychiatry 2013;74:723-731, quiz 731
73. Biederman J, Petty CR, Monuteaux MC, et al: The Child Behavior Checklist-Pediatric Bipolar Disorder profile predicts a subsequent diagnosis of bipolar disorder and associated impairments in ADHD youth growing up: a longitudinal analysis. J Clin Psychiatry 2009;70:732-740
74. Reichart CG, van der Ende J, Wals M, et al: The use of the GBI as predictor of bipolar disorder in a population of adolescent offspring of parents with abipolar disorder. J Affect Disord 2005;89:147-155
75. Blechert J, Meyer TD: Are measures of hypomanic personality, impulsive nonconformity and rigidity predictors of bipolar symptoms? Br J Clin Psychol 2005;44:15-27
76. Kwapil TR, Miller MB, Zinser MC, et al: A longitudinal study of high scorers on the hypomanic personality scale. J Abnorm Psychol 2000;109:222-226
77. Goodday SM, Preisig M, Gholamrezaee M, et al: The association between self-reported and clinically determined hypomanic symptoms and the onset of major mood disorders. BJPsych Open 2017;3:71-77
78. Meyer SE, Carlson GA, Youngstrom E, et al: Long-term outcomes of youth who manifested the CBCL-Pediatric Bipolar Disorder phenotype during childhood and/or adolescence. J Affect Disord 2009;113:227-235
79. Mesman E, Youngstrom EA, Juliana NK, et al: Validation of the Seven Up Seven Down Inventory in bipolar offspring: screening and prediction of mood disorders. Findings from the Dutch Bipolar Offspring Study. J Affect Disord 2017;207:95-101
80. Youngstrom EA, Freeman AJ, Jenkins MM: The assessment of children and adolescents with bipolar disorder. Child Adolesc Psychiatr Clin N Am 2009;18:353-390, viii-ix [viii-ix.]
81. Bechdolf A, Ratheesh A, Cotton SM, et al: The predictive validity of bipolar at-risk (prodromal) criteria in help-seeking adolescents and young adults: a prospective study. Bipolar Disord 2014;16:493-504
82. Mitchell PB, Wilhelm K, Parker G, et al: The clinical features of bipolar depression: a comparison with matched major depressive disorder patients. J Clin Psychiatry 2001;62:212-216, quiz 217
83. Leopold K, Ritter P, Correll CU, et al: Risk constellations prior to the development of bipolar disorders: rationale of a new risk assessment tool. J Affect Disord 2012;136:1000-1010
84. Correll CU, Olvet DM, Auther AM, et al: The Bipolar Prodrome Symptom Interview and Scale-Prospective (BPSS-P): description and validation in a psychiatric sample and healthy controls. Bipolar Disord 2014;16:505-522
85. Hafeman DM, Merranko J, Goldstein TR, et al: Assessment of a person-level risk calculator to predict new-onset bipolar spectrum disorder in youth at familial risk. JAMA Psychiatry 2017;74:841-847
86. Fernandes BS, Williams LM, Steiner J, et al: The new field of 'precision psychiatry'. BMC Med 2017;15:80
87. Vieta E: DSM-5.1. Acta Psychiatr Scand 2016;134:187-188
88. Whalley HC, Sussmann JE, Romaniuk L, et al: Prediction of depression in individuals at high familial risk of mood disorders using functional magnetic resonance imaging. PLoS One 2013;8:e57357
89. Mourão-Miranda J, Oliveira L, Ladouceur CD, et al: Pattern recognition and functional neuroimaging help to discriminate healthy adolescents at risk for mood disorders from low risk adolescents. PLoS One 2012;7:e29482
90. Sugranyes G, Solé-Padullés C, de la Serna E, et al: Cortical morphology characteristics of young offspring of patients with schizophrenia or bipolar disorder. J Am Acad Child Adolesc Psychiatry 2017;56:79-88
91. Snijders G, de Witte L, Mesman E, et al: The seroprevalence of antithyroid peroxidase antibodies in bipolar families and bipolar twins: results from two longitudinal studies. Int J Bipolar Disord 2017;5:1
92. Goodday SM, Horrocks J, Keown-Stoneman C, et al: Repeated salivary daytime cortisol and onset of mood episodes in offspring of bipolar parents. Int J Bipolar Disord 2016;4:12
93. Singh MK, Jo B, Adleman NE, et al: Prospective neurochemical characterization of child offspring of parents with bipolar disorder. Psychiatry Res 2013;214:153-160
94. Padmos RC, Hillegers MH, Knijff EM, et al: A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes. Arch Gen Psychiatry 2008;65:395-407
95. Mesman E, Hillegers MH, Ambree O, et al: Monocyte activation, brain-derived neurotrophic factor (BDNF), and S100B in bipolar offspring: a follow-up study from adolescence into adulthood. Bipolar Disord 2015;17:39-49
96. Snijders G, Schiweck C, Mesman E, et al: A dynamic course of T cell defects in individuals at risk for mood disorders. Brain Behav Immun 2016;58:11-17
97. Hayes JF, Khandaker GM, Anderson J, et al: Childhood interleukin-6, C-reactive protein and atopic disorders as risk factors for hypomanic symptoms in young adulthood: a longitudinal birth cohort study. Psychol Med 2017;47:23-33
98. Hidalgo-Mazzei D, Murru A, Reinares M, et al: Big Data in mental health: a challenging fragmented future. World Psychiatry 2016;15:186-187
99. W Adams Z, McClure EA, Gray KM, et al: Mobile devices for the remote acquisition of physiological and behavioral biomarkers in psychiatric clinical research. J Psychiatr Res 2017;85:1-14
100. Luo W, Phung D, Tran T, et al: Guidelines for developing and reporting machine learning predictive models in biomedical research: a multidisciplinary view. J Med Internet Res 2016;18:e323
101. Vieta E: The bipolar maze: a roadmap through translational psychopathology. Acta Psychiatr Scand 2014;129:323-327
102. Rosa AR, Magalhães PV, Czepielewski L, et al: Clinical staging in bipolar disorder: focus on cognition and functioning. J Clin Psychiatry 2014;75:e450-e456
103. Ratheesh A, Cotton SM, Davey CG, et al: Ethical considerations in preventive interventions for bipolar disorder. Early Interv Psychiatry 2017;11:104-112
104. Berk M, Brnabic A, Dodd S, et al: Does stage of illness impact treatment response in bipolar disorder? Empirical treatment data and their implication for the staging model and early intervention. Bipolar Disord 2011;13:87-98
105. Colom F, Vieta E, Sánchez-Moreno J, et al: Group psychoeducation for stabilised bipolar disorders: 5-year outcome of a randomised clinical trial. Br J Psychiatry 2009;194:260-265
106. Morriss R, Lobban F, Riste L, et al: Clinical effectiveness and acceptability of structured group psychoeducation versus optimised unstructured peer support for patients with remitted bipolar disorder (PARADES): a pragmatic, multicentre, observer-blind, randomised controlled superiority trial. Lancet Psychiatry 2016;3:1029-1038
107. Vieta E, Morilla I: Early group psychoeducation for bipolardisorder. Lancet Psychiatry 2016;3:1000-1001
108. Miklowitz DJ, Schneck CD, George EL, et al: Pharmacotherapy and family-focused treatment for adolescents with bipolar I and II disorders: a 2-year randomized trial. Am J Psychiatry 2014;171:658-667
109. Miklowitz DJ, Schneck CD, Singh MK, et al: Early intervention for symptomatic youthatrisk for bipolar disorder: arandomizedtrial of family-focused therapy. J Am Acad Child Adolesc Psychiatry 2013;52:121-131
110. Nadkarni RB, Fristad MA: Clinical course of children with a depressive spectrum disorder and transient manic symptoms. Bipolar Disord 2010;12:494-503
111. Goldstein TR, Fersch-Podrat R, Axelson DA, et al: Early intervention for adolescents at high risk for the development of bipolar disorder: pilot study of Interpersonal and Social Rhythm Therapy (IPSRT). Psychotherapy (Chic) 2014;51:180-189
112. Berk M, Parker G: The elephant on the couch: side-effects of psychotherapy. Aust N Z J Psychiatry 2009;43:787-794
113. Vieta E: Staging and psychosocial early intervention in bipolar disorder. Lancet Psychiatry 2015;2:483-485
114. Hidalgo-Mazzei D, Mateu A, Reinares M, et al: Internet-based psychological interventions for bipolar disorder: Review of the present and insights into the future. J Affect Disord 2015;188:1-13
115. Lauder S, Chester A, Castle D, et al: Arandomized headto head trial of MoodSwings.net.au: an Internet based self-help program for bipolar disorder. J Affect Disord 2015;171:13-21
116. Kessing LV, Vradi E, Andersen PK: Starting lithium prophylaxis early v. late in bipolar disorder. Br J Psychiatry 2014;205:214-220
117. Chang KD, Dienes K, Blasey C, et al: Divalproex monotherapy inthe treatment of bipolar offspring with mood and behavioral disorders and at least mild affective symptoms. J Clin Psychiatry 2003;64:936-942
118. DelBello MP, Adler CM, Whitsel RM, et al: A 12-week single-blind trial of quetiapine for the treatment of mood symptoms in adolescents at high risk for developing bipolar I disorder. J Clin Psychiatry 2007;68:789-795
119. Findling RL, Frazier TW, Youngstrom EA, et al: Double-blind, placebo-controlled trial of divalproex monotherapy in the treatment of symptomatic youth at high risk for developing bipolar disorder. J Clin Psychiatry 2007;68:781-788
120. Jerrell JM, McIntyre RS, Tripathi A: Childhood treatment with psychotropic medication and development of comorbid medical conditions in adolescent-onset bipolar disorder. Hum Psychopharmacol 2011;26:451-459
121. McNamara RK, Nandagopal JJ, Strakowski SM, et al: Preventative strategiesforearly-onsetbipolar disorder: towardsaclinical staging model. CNS Drugs 2010;24:983-996
122. Joffe H, Cohen LS, Suppes T, et al: Longitudinal follow-up of reproductive and metabolic features of valproate-associated polycystic ovarian syndrome features: A preliminary report. Biol Psychiatry 2006;60:1378-1381
123. Joffe H, Cohen LS, Suppes T, et al: Valproateis associated with newon set oligoamenorrhea with hyperandrogenism in women with bipolar disorder. Biol Psychiatry 2006;59:1078-1086
124. Birmaher B, Axelson D, Goldstein B, et al: Four-year longitudinal course of children and adolescents withbipolar spectrumdisorders: the Course and Outcome of Bipolar Youth (COBY) study. Am J Psychiatry 2009;166:795-804
125. Sharpley AL, Hockney R, McPeake L, et al: Folic acid supplementation for prevention of mood disorders in young people at familial risk: a randomised, double blind, placebo controlled trial. J Affect Disord 2014;167:306-311
126. McGorry PD, Nelson B, Markulev C, et al: Effect of v-3 polyunsaturated fatty acids in young people at ultrahigh risk for psychotic disorders: the NEURAPRO Randomized Clinical Trial. JAMA Psychiatry 2017;74:19-27
127. Pusceddu MM, Kelly P, Stanton C, et al: N-3 polyunsaturated fatty acids through the lifespan: implication for psychopathology. Int J Neuropsychopharmacol 2016;19:pyw078
128. Williams LJ, Pasco JA, Mohebbi M, et al: Statin and aspirin use and the risk of mood disorders among men. Int J Neuropsychopharmacol 2016;19:pyw008
129. Miskowiak KW, Carvalho AF, Vieta E, et al: Cognitive enhancement treatments for bipolar disorder: A systematic review and methodological recommendations. Eur Neuropsychopharmacol 2016;26:1541-1561
130. Drago A, Serretti A, Smith R, et al: No association between genetic markers in BDNF gene and lithium prophylaxis in a Greek sample. Int J Psychiatry Clin Pract 2010;14:154-157
131. Perlis RH, Smoller JW, Ferreira MA, et al: A genomewide association study of response to lithium for prevention of recurrence in bipolar disorder. Am J Psychiatry 2009;166:718-725
132. Hou L, Heilbronner U, Degenhardt F, et al: Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study. Lancet 2016;387:1085-1093
133. Singh AB, Bousman CA: Antidepressant pharmacogenetics. Am J Psychiatry 2017;174:417-418
134. Berk M, Conus P, Lucas N, et al: Setting the stage: from prodrome to treatment resistance in bipolar disorder. Bipolar Disord 2007;9:671-678
135. Kapczinski F, Dias VV, Kauer-Sant'Anna M, et al: Clinical implications of a staging model for bipolar disorders. Expert Rev Neurother 2009;9:957-966
136. Vieta E, Reinares M, Rosa AR: Staging bipolar disorder. Neurotox Res 2011;19:279-285
137. Grande I, Magalhães PV, Chendo I, et al: Staging bipolar disorder: clinical, biochemical, and functional correlates. Acta Psychiatr Scand 2014;129:437-444
138. Diler RS, Goldstein TR, Hafeman D, et al: Characteristics of depression among offspring at high and low familial risk of bipolar disorder. Bipolar Disord 2017;19:344-352
139. Bechdolf A, Wood SJ, Nelson B, et al: Amygdala and insula volumes prior to illness onset in bipolar disorder: a magnetic resonance imaging study. Psychiatry Res 2012;201:34-39
140. Berk M, Hallam K, Malhi GS, et al: Evidence and implications for early intervention in bipolar disorder. J Ment Health 2010;19:113-126
141. McGorry PD: Risk syndromes, clinical staging and DSM V: new diagnostic infrastructure for early intervention in psychiatry. Schizophr Res 2010;120:49-53
142. Fernandes BS, Berk M. Staginginbipolardisorder: one stepcloserto precision psychiatry. Rev Bras Psiquiatr 2017;39:88-89
143. Salvador R, Radua J, Canales-Rodríguez EJ, et al: Evaluation of machine learning algorithms and structural features for optimal MRI-based diagnostic prediction in psychosis. PLoS One 2017;12:e0175683
144. Post RM, Altshuler LL, Kupka R, et al.: More childhood onset bipolar disorder in the United States than Canada or Europe: Implications for treatment and prevention. Neurosci Biobehav Rev 2017;74(Pt A):204-213
145. Lambert M, Niehaus V, Correll C: Pharmacotherapyinchildrenand adolescents at clinical-high risk for psychosis and bipolar disorder. Pharmacopsychiatry 2016;49:229-244
146. Kessing LV, Hansen HV, Hvenegaard A, et al: Treatment in a specialised out-patient mood disorder clinic v. standard out-patient treatment in the early course of bipolar disorder: randomised clinical trial. Br J Psychiatry 2013;202:212-219
147. Garrido JM, Sánchez-Moreno J, Vázquez M, et al: Evaluation of patient satisfaction in a state reference center of bipolar disorder. J Behav Health Serv Res (Epub ahead of print, July 13, 2017)
148. Mas S, Gasso P, Torra M, et al. Intuitive pharmacogenetic dosing of risperidone according to CYP2D6 phenotype extrapolated from genotype in a cohort of first episode psychosis patients. Eur Neuropsychopharmacol 2017;27:647-656
149. Solé B, Vieta E, Martinez-Aran A. Thinking ahead: executive dysfunction in bipolar disorder. Eur Neuropsychopharmacol 2016;26:1348-1349
150. Solé B, Jiménez E, Torrent C, et al: Cognitive impairment in bipolar disorder: treatment and prevention strategies. Int J Neuropsychopharmacol 2017;20:670-680
151. Forcada I, Mur M, Mora E, et al: The influence of cognitive reserve on psychosocial and neuropsychological functioning in bipolar disorder. Eur Neuropsychopharmacol 2015;25:214-222
152. Anaya C, Torrent C, Caballero FF, et al: Cognitive reservein bipolar disorder: relationtocognition, psychosocial functioning and quality of life. Acta Psychiatr Scand 2016;133:386-398
153. Amoretti S, Bernardo M, Bonnin CM, et al.: The impactof cognitive reserve in the outcome of first-episode psychoses: 2-year follow-up study. Eur Neuropsychopharmacol 2016;26:1638-1648.
154. Grande I, Sanchez-Moreno J, Solé B, et al: High cognitive reserve in bipolar disorders as a moderator of neurocognitive impairment. J Affect Disord 2017;208:621-627
155. Passos IC, Mwangi B, Vieta E, et al: Areas of controversy in neuroprogression in bipolar disorder. Acta Psychiatr Scand 2016;134:91-103
156. O'Neil A, Jacka FN, Quirk SE, et al: A shared framework for the common mental disorders and non-communicable disease: key considerations for disease prevention and control. BMC Psychiatry 2015;15:15
157. Woodberry KA, Shapiro DI, Bryant C, et al: Progress and future directions in research on the psychosis prodrome: a review for clinicians. Harv Rev Psychiatry 2016;24:87-103